Centre Hospitalier De Saint-Denis
- Address
- lock Available on a paid plan
Oncology and Digestive Cancer Research
At Centre Hospitalier De Saint-Denis, clinical research in oncology is strongly focused on colorectal cancer, colon carcinoma, small bowel adenocarcinoma, and ampullary adenocarcinoma. These studies are designed to improve treatment effectiveness, refine surgery-related strategies, and evaluate new combinations of cancer therapy for people with locally advanced or metastatic disease.
- Testing better treatment approaches for colorectal cancer and colon carcinoma
- Evaluating therapy options for small bowel adenocarcinoma and ampullary adenocarcinoma
- Improving the success of digestive system cancer care through new treatment strategies
These trials reflect a broad effort to advance care for digestive tract neoplasms while supporting more personalized and effective cancer treatment.
Emergency Care, Stroke, and Cardiovascular Diseases
The site also conducts important studies in stroke, ischemic stroke, large vessel occlusion, myocardial infarction, and other cardiovascular diseases. Research here aims to improve urgent treatment decisions, restore blood flow more effectively, and strengthen outcomes for patients with time-sensitive vascular emergencies.
- Comparing treatment strategies for large ischemic stroke and large vessel occlusion
- Assessing ways to improve recovery after cerebral infarction and transient ischemic attack
- Studying therapies that may reduce complications in cardiovascular disease
These investigations support faster and more effective care for patients facing serious neurological and cardiac emergencies.
Infectious Diseases and Critical Care
Research in infectious diseases at this hospital includes ventilator-associated pneumonia, sepsis, severe bacterial infections, HIV, and herpes simplex virus encephalitis. Many of these studies focus on improving infection control, comparing antibiotic strategies, and identifying safer ways to manage serious illness in intensive care.
- Evaluating better treatment choices for ventilator-associated pneumonia and sepsis
- Studying approaches to reduce antibiotic use while maintaining effectiveness
- Exploring improved care for HIV and severe viral or bacterial infections
The research aims to help clinicians choose treatments that are both effective and appropriate for critically ill patients.
Maternal, Neonatal, and Pediatric Care
Another major area of work covers pregnancy complications, postpartum hemorrhage, preterm rupture of membranes, neonatal respiratory distress, and newborn resuscitation. These studies are focused on improving outcomes for mothers, babies, and children through better emergency care, symptom relief, and prevention of complications.
- Testing strategies to reduce bleeding and complications after delivery
- Improving care for preterm birth and newborn respiratory problems
- Assessing methods to support delivery room resuscitation and pediatric pain control
Work in this area highlights the hospital’s interest in safer obstetric and neonatal care, especially in urgent clinical situations.
Neurology, Metabolic Disorders, and Supportive Care
Clinical trials also address neurological and metabolic conditions such as hereditary retroperitoneal fibrosis, severe hyponatremia, sarcoidosis, and pain related to sickle cell disease. The purpose of this research is to improve symptom control, protect patients from treatment-related complications, and clarify the value of supportive therapies.
- Studying ways to prevent dangerous changes in blood sodium levels
- Evaluating pain relief and comfort measures in sickle cell disease
- Assessing treatments that may improve longer-term recovery in neurological and inflammatory conditions
These studies show a strong interest in supportive care that can make treatment safer and more tolerable for patients with complex illnesses.
Digestive System Disease and Hepatic Research
The research portfolio includes studies of cirrhosis, portal hypertension, and related complications, with the goal of improving how liver disease is managed over time. Investigators are also examining treatment approaches that may better control pressure changes in the liver and reduce the risk of serious outcomes.
- Improving management of portal hypertension in cirrhosis
- Testing therapies that may reduce complications of advanced digestive system disease
- Exploring ways to strengthen long-term liver-related care
This work adds an important gastroenterology dimension to the site’s broader clinical research activity.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 of 16 therapeutic areas and 15 of 79 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 62 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
lock +9 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +2 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centre Hospitalier De Saint-Denis
lock Showing 1 of 28 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Comparative Study of Doravirine/Lamivudine Versus Dolutegravir/Lamivudine for Maintenance Therapy in HIV Patients with Suppressed Viral Load | ANRS Maladies Infectieuses Emergentes, Centre De Recherches Et D'Etudes Sur La Pathologie Tropicale Et Le Sida | Phase III | Recruiting | Apr 2025 | — |
IMP list
lock Showing 1 of 79 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Fluorouracil | 6 | Unknown | 2024-02-09 | 2026-05-07 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.
